Impact of cystatin-C level on the prevalence and angiographic characteristics of vasospastic angina in Korean patients

International Heart Journal
Su Nam LeeKi-Bae Seung

Abstract

Cystatin-C, a marker of mild renal dysfunction, has been reported to be associated with cardiovascular diseases including vasospastic angina (VSA). We aimed to investigate the impact of cystatin-C level on the prevalence and angiographic characteristics of VSA in Korean patients.A total of 549 patients in the VA-KOREA (Vasospastic Angina in KOREA) registry who underwent ergonovine provocation tests were consecutively enrolled. Estimated glomerular filtration rate (eGFR) and levels of serum creatinine (Cr) and cystatin-C were assessed before angiography.The patients were classified into two groups: the VSA group (n = 149, 27.1%) and the non-VSA group (n = 400). Although eGFR and Cr levels were similar between the two groups, the VSA group had a significantly higher level of cystatin-C (P < 0.05). A high level of cystatin-C (second tertile, hazard ratio 1.432; 95% confidence interval [1.1491.805]; P = 0.026, third tertile, 1.947 [1.132-2.719]; P = 0.003) and current smoking (2.710 [1.415-4.098]; P < 0.001) were independently associated with the prevalence of VSA. Furthermore, the highest level of cystatin-C (> 0.96 ng/mL) had a significant impact on the incidence of multivessel spasm (2.608 [1.061-4.596]; P = 0.037).A high level ...Continue Reading

References

Dec 10, 1997·Internal Medicine·H Yasue, K Kugiyama
Jun 30, 2000·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·E CollA Darnell
Jan 3, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·D Fliser, E Ritz
Sep 24, 2004·The New England Journal of Medicine·Alan S GoChi-yuan Hsu
May 20, 2005·The New England Journal of Medicine·Michael G ShlipakCatherine Stehman-Breen
Dec 27, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Mahmut Ilker YilmazCarmine Zoccali
Feb 24, 2006·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Stein HallanJostein Holmen
Jan 18, 2008·Journal of the American Society of Nephrology : JASN·Mahmut Ilker YilmazJonas Axelsson
Jun 5, 2008·Journal of cardiology·Hirofumi YasueYuji Mizuno
Oct 1, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Anh L BuiMichael G Shlipak
Jan 6, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Lulu HanXiang-mei Chen
Jun 19, 2010·International Heart Journal·Yoshinobu MorikawaHirofumi Yasue
Jul 31, 2010·Circulation Journal : Official Journal of the Japanese Circulation Society·UNKNOWN JCS Joint Working Group
Oct 6, 2010·Circulation Journal : Official Journal of the Japanese Circulation Society·Arihiro KiyosueRyozo Nagai
May 12, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·Seiji KogaKoji Maemura
Jul 26, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·Akira FunayamaIsao Kubota
Sep 22, 2011·Journal of Korean Medical Science·Hye Rim AnKyu Bok Choi
Oct 19, 2011·Circulation·Gaetano Antonio LanzaFilippo Crea
Aug 7, 2013·Journal of the American College of Cardiology·Yusuke TakagiUNKNOWN Japanese Coronary Spasm Association
Sep 13, 2013·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Antoine BouquegneauMartin Flamant

❮ Previous
Next ❯

Citations

May 14, 2016·International Heart Journal·Koichi KimuraIssei Komuro
Apr 4, 2017·International Heart Journal·Yusuke AdachiShin-Ichi Momomura
Oct 23, 2019·BioMed Research International·Liang LiChao Feng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

© 2022 Meta ULC. All rights reserved